Pharmabiz

AIOCD seeks PM’s intervention to stop illegal e-pharmacies & withdraw proposed regulations GSR 817 & 220

AIOCD seeks PM’s intervention to stop illegal e-pharmacies & withdraw proposed regulations GSR 817 & 220: Peethaambaran ...
Pharmabiz

APTI Karnataka to strengthen academic-industry synergies at IPC 2025 to be held from Dec 19-21 in Bengaluru

APTI Karnataka to strengthen academic-industry synergies at IPC 2025 to be held from Dec 19-21 in Bengaluru: Nandita Vijayasimha, Bengaluru Friday, December 12, 2025, 08:00 Hrs [I ...
Pharmabiz

KPCMA urges state govt to revise D Pharm fees from Rs. 14,300 to Rs. 40,000 to cover operational costs

KPCMA urges state govt to revise D Pharm fees from Rs. 14,300 to Rs. 40,000 to cover operational costs: Nandita Vijayasimha, Bengaluru Friday, December 12, 2025, 08:00 Hrs [IST] T ...
Pharmabiz

DGFT issues updated list of PSIAs and approved instruments to ensure regulatory compliance

DGFT issues updated list of PSIAs and approved instruments to ensure regulatory compliance: Shardul Nautiyal, Mumbai Friday, December 12, 2025, 08:00 Hrs [IST] The Directorate Gen ...
Pharmabiz

Senores Pharma bags Pharmaceutical Excellence Award at Hurun Stars of Gujarat 2025

Senores Pharma bags Pharmaceutical Excellence Award at Hurun Stars of Gujarat 2025: Our Bureau, Bengaluru Thursday, December 11, 2025, 17:30 Hrs [IST] Senores Pharmaceuticals is i ...
Pharmabiz

Quanterix-Lucent & Emocog enter exclusive Korea distribution agreement for Simoa platform for blood-based Alzheimer’s diagnostics

Quanterix-Lucent & Emocog enter exclusive Korea distribution agreement for Simoa platform for blood-based Alzheimer’s diagnostics: Seoul, Republic of Korea Thursday, December 11 ...
Pharmabiz

NHSA of China adds generic lecanemab in its commercial insurance innovative drug list to treat early Alzheimer’s disease

NHSA of China adds generic lecanemab in its commercial insurance innovative drug list to treat early Alzheimer’s disease: Tokyo Thursday, December 11, 2025, 16:00 Hrs [IST] Toky ...
Pharmabiz

Gilead Foundation awards over $3 million to support people living with metastatic breast cancer

Gilead Foundation announced a commitment of more than $3 million in new grants to help address critical gaps in education, care delivery and support services for people affected by metastatic breast ...
Pharmabiz

US FDA grants Orphan Drug Designation to GSK’227, a B7-H3-targeted antibody-drug conjugate to treat small-cell lung cancer

US FDA grants Orphan Drug Designation to GSK’227, a B7-H3-targeted antibody-drug conjugate to treat small-cell lung cancer: London, UK Thursday, December 11, 2025, 09:00 Hrs [IS ...
Pharmabiz

Polpharma Biologics and Libbs Farmacêutica ink licensing agreement for biosimilar for autoimmune diseases in Brazilian market

Polpharma Biologics and Libbs Farmacêutica ink licensing agreement for biosimilar for autoimmune diseases in Brazilian market: Switzerland Thursday, December 11, 2025, 11:00 Hrs ...
Pharmabiz

Arrowhead Pharma doses first subjects in phase 1/2a study of ARO-MAPT to treat Alzheimer’s disease and other tauopathies

Arrowhead Pharma doses first subjects in phase 1/2a study of ARO-MAPT to treat Alzheimer’s disease and other tauopathies: Pasadena, California Thursday, December 11, 2025, 12:00 ...
Pharmabiz

WHO & European Commission’s HERA sign €3.5 mn agreement to expand partnership to combat antimicrobial resistance under EU4Health programme

WHO & European Commission’s HERA sign €3.5 mn agreement to expand partnership to combat antimicrobial resistance under EU4Health programme: Geneva Thursday, December 11, 2025, ...